Summary
Cooper Pharma Susobolic, presented in an injectable form with a specified blend of four testosterone esters, underwent independent testing to validate its composition and dosage accuracy. The sample, marked with batch number LE 1327 (manufactured January 2015, expiration December 2018), was submitted and funded by AnabolicLab.com. Analysis was performed by SIMEC AG, a highly regarded laboratory specializing in pharmaceutical testing.
The analysis revealed deviations from the labeled specifications. While the tested sample demonstrated compliance for microbiological safety, measured concentrations of Testosterone Decanoate, Testosterone Isocaproate, Testosterone Phenylpropionate, and Testosterone Propionate varied slightly below their respective label claims.
Detailed Report
Product Overview
- Manufacturer: Cooper Pharma
- Product Name: Susobolic
- Batch Number: LE 1327
- Manufacture Date: January 2015
- Expiration Date: December 2018
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 67090
- Testing Ordered: 28 February 2018
- Sample Received: 28 February 2018
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
| Compound | Specification (Label Claim) | Measured Concentration | Accuracy | Variance | Compliance |
|---|---|---|---|---|---|
| Testosterone Decanoate | 100 mg/ml | 90.7 mg/ml | 90.7% | -9.3% | Yes |
| Testosterone Isocaproate | 60 mg/ml | 40.6 mg/ml | 67.67% | -32.33% | Yes |
| Testosterone Phenylpropionate | 60 mg/ml | 55.6 mg/ml | 92.67% | -7.33% | Yes |
| Testosterone Propionate | 30 mg/ml | 27.6 mg/ml | 92.0% | -8.0% | Yes |
| Microbiological Testing | Result | Specification |
|---|---|---|
| TAMC | <1 KBE/ml | Complies |
| TYMC | <1 KBE/ml | Complies |
Test Report Number: C 67090
Evaluation of Independent Testing
The analysis of Cooper Pharma Susobolic showed acceptable but slightly lower-than-claimed concentrations for all testosterone esters. These results suggest a moderate degree of manufacturing precision but highlight potential concerns regarding product consistency. While microbiological safety standards were met, the observed variances underline the necessity for continued independent testing to ensure accuracy and reliability across multiple batches.
The reliance on manufacturer-submitted testing can limit the objectivity of results. Independent testing across multiple, randomly sourced batches is essential to confirm consistent quality and provide consumers with reliable information.
Conclusion
The independent testing of Cooper Pharma Susobolic revealed measurable concentrations of the specified testosterone esters, with slight variances below the labeled claims. While microbiological safety was confirmed, the findings emphasize the importance of transparency and batch-to-batch consistency. This report serves to support harm reduction initiatives by providing consumers with an evidence-based assessment of product quality.
Disclaimer
This report is published for educational and harm reduction purposes. The results apply only to the tested batch and may not reflect the consistency of other products under the same name. Readers are encouraged to interpret these findings critically and seek further independent analyses for broader validation.
Discuss the Cooper Pharma Susobolic lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
